Skip to content

Economic Calendar Earnings Calendar MakklerPRO

Log In Get Started Free

Overview Stocks Crypto Currencies Commodities ETFs Options Guru Portfolios My watchlist

Makkler App

Faster and clearer

Skip to content

Economic Calendar Earnings Calendar MakklerPRO

Log In Get Started Free

Overview/Stocks/UTHR

United Therapeutics Corporation UTHR

NASDAQHealth TechnologyUnited States

$591.17-2.14 (-0.36%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 587.00598.84
52-week range: 455.63614.23

Financial health

– / 5

Analyst view · 17 firms

Buy14 buy · 2 hold · 1 sell

Avg. target $687.14 (+16.2%)

Overview Financials Analysis Earnings Technicals Historical data News

Prices may be delayed and are for informational purposes only - not investment advice.

Guru Portfolios

See with MakklerPRO

The portfolio-sharing platform connecting finance analysts with an audience that wants to learn.

Markets

All markets
Stocks
Crypto
Currencies
Commodities
ETFs
My watchlist

Research

News
Economic Calendar
Earnings Calendar
MakklerAI
Famous Investors

Community

Clubs

Company

Legal

Popular searches

Indices

Borsa Istanbul

US stocks

FX and commodities

Crypto

© 2026 Makkler, LLC. All rights reserved. Content on this platform does not constitute investment advice.

Prices may be delayed depending on the data source.

Makkler, LLC · 30 N Gould St, STE R, Sheridan, WY 82801, United States

Language

Theme

Your research starts here.

Become an Analyst

Terms of Service

Data Protection Notice

Risk Disclosure

THYAOTurkish Airlines

GARANGaranti BBVA

KCHOLKoç Holding

Full-screen chart

Nov 13, 2026, 09:00 PMOpen $591.17High $591.17Low $591.17Close $591.17(-0.02%)

$610.38$562.11

Oct 28, 2026, 05:30 PMNov 13, 2026, 09:00 PM

1 Day-0.36%

1 Week+5.19%

1 Month+8.79%

3 Months+17.93%

1 Year+27.88%

5 Years+190.74%

USD · 15 min delayed · Price return · dividends not includedTradingView Lightweight Charts

Key statistics

Profitability and valuation from the filed statements

Price and trading

Previous close: $593.31
Day range: $587.00 – $598.84
Volume: 463.50K
Avg. volume (1Y): 541.27K
Beta: 0.48
Volatility (1 year): 35.1%

Valuation

Market cap: $25.18B
P/E (TTM): 22.31

UTHR with MakklerAIPRO

Answers from price, statements, peer and news data. Not investment advice.

MakklerAI question

MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO

UTHR news

Next report

Feb 24, 2027

in 101 days · ·

Technical view

Above averages

20D avg.584.0250D avg.542.60200D avg.537.46

Where the price sits against its 50- and 200-day moving averages.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: United States
Exchange: NASDAQ
IPO date: 1999-06-17
Shares outstanding: 42.59M

Price / Book

4.34

EV / EBITDA

15.57

Dividend yield (annualized)

0.00%

Makkler Fair Value

Unlock with MakklerPRO

Profitability · trailing 12 months

Revenue: $3.19B
EBITDA: $1.42B
Net Income: $1.23B
EPS (TTM): $26.50
Net margin: 38.6%
Return on equity (ROE): 19.6%

Employees

1,400

ISIN

US91307C1027

Beta

0.48

Website

www.unither.com

Similar companies

NBIXNeurocrine Biosciences, Inc.P/E 24.8
BBIOBridgeBio Pharma, Inc.—
IQVIQVIA Holdings IncP/E 32.2
NTRANatera, Inc.—

Peer comparison

United Therapeutics Faces Slower Growth and Margin Pressure, StockStory Says

The publisher cites weaker revenue expectations and declines in operating and cash-flow margins, despite United Therapeutics’ past revenue growth.

Makkler Newsroom · Oct 7, 06:52 PM · 1 min read

Expected date